18
Participants
Start Date
March 31, 2011
Primary Completion Date
March 31, 2015
Study Completion Date
March 31, 2015
Adalimumab 40 MG/0.8 ML Subcutaneous Solution [HUMIRA]
40mg subcutaneously, every other week for 6 months
UNC Dermatology Clinical Trials Unit, Chapel Hill
Collaborators (1)
AbbVie
INDUSTRY
University of North Carolina, Chapel Hill
OTHER